Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Participant Follow-Up and Retention

Posted on By

Standard Operating Procedure for Ensuring Participant Follow-Up and Retention in Clinical Research

Purpose

This SOP outlines the procedures for conducting follow-up with participants and ensuring their retention in clinical trials and clinical studies. The goal is to maintain high levels of participant engagement, adherence, and retention to support study integrity and data quality.

Scope

This SOP applies to all personnel involved in participant follow-up and retention in clinical trials and clinical studies, including principal investigators, clinical research coordinators, study nurses, and other study team members.

Responsibilities

  • Principal Investigator (PI): Oversees participant follow-up and retention processes and ensures compliance with study protocols and regulations.
  • Clinical Research Coordinators: Coordinate and conduct participant follow-up visits and maintain communication with participants.
  • Study Nurses and Medical Personnel: Conduct participant assessments and provide medical care as needed during follow-up visits.
  • Data Management Team: Manage data collection and documentation during follow-up visits and participant interactions.
See also  SOP for Use of Placebos and Comparator Products

Procedure

  • Scheduling Follow-Up Visits:
    • Schedule follow-up visits according to the study protocol and participant availability.
    • Provide participants with advance notice and reminders about upcoming visits.
  • Conducting Follow-Up Visits:
    • Perform assessments and collect data according to the study protocol during follow-up visits.
    • Address participant questions and concerns during visits to maintain engagement.
    • Monitor participant adherence to the study regimen and provide support as needed.
  • Communication and Engagement:
    • Maintain regular communication with participants
through various channels (e.g., phone, email, text).
  • Provide participants with study updates and information to keep them informed and engaged.
  • Offer support and resources to address participant concerns and maintain their commitment to the study.
  • Retention Strategies:
    • Develop and implement strategies to enhance participant retention (e.g., incentives, transportation assistance).
    • Monitor participant retention rates and identify factors affecting retention.
    • Take proactive measures to address retention challenges and improve participant engagement.
  • Documentation and Reporting:
    • Document follow-up visits, assessments, and participant interactions accurately and promptly.
    • Track and report participant retention rates and follow-up outcomes.
  • Training and Education:
    • Provide training to study personnel on follow-up and retention processes and best practices.
    • Offer ongoing education and support to ensure adherence to follow-up and retention protocols.
  • Abbreviations Used

    • SOP: Standard Operating Procedure
    • PI: Principal Investigator

    Documents

    • Follow-up visit schedules and reminders
    • Participant assessments and data collection forms
    • Communication logs and participant interactions
    • Retention reports and monitoring logs
    • Training materials

    References

    • Institutional policies for participant follow-up and retention
    • Regulatory guidelines (e.g., FDA, EMA, ICH-GCP)
    • Study protocols and investigator brochures

    SOP Version

    Version: 1.0

    See also  SOP for Interim Analysis and Data Monitoring Committees
    Clinical Studies Tags:Adverse event reporting, Clinical data management, Clinical data validation, Clinical research compliance, Clinical research coordination, Clinical site selection, clinical studies, clinical study, Clinical study protocols, Clinical trial management, Clinical trial monitoring, Clinical trial participants, Clinical trial procedures, Clinical trial SOPs, clinical trials, Conflict of interest management, Data collection methods, Data management SOPs, eCRF validation, Electronic record-keeping guidelines, Electronic systems validation, Ethics committee reporting, Investigator training protocols, Participant data privacy, Participant recruitment strategies, Pharmacovigilance protocols, Quality assurance practices, Regulatory compliance procedures, Risk management procedures, Safety monitoring procedures, Site selection criteria, Study protocol development

    Post navigation

    Previous Post: SOP for Training and Certification of Study Personnel
    Next Post: SOP for Site Close-Out and Study Termination

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version